Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study
Status:
Withdrawn
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the feasibility of prospectively enrolling and
randomizing patients with aneurysmal subarachnoid hemorrhage (aSAH) to receive levetiracetam
or not to receive levetiracetam, and documenting in-hospital and follow-up clinical
variables.
Phase:
Phase 4
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center